Company:  MIMEDX GROUP, INC. (MDXG)
Form Type:  8-K
Filing Date:  5/19/2017 
CIK:  0001376339 
Address:  1775 W OAK COMMONS COURT, NE 
City, State, Zip:  MARIETTA, Georgia 30062 
Telephone:  678-384-6720 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$14.84  
Change: 
-0.15 (-1.00%)  
Trade Time: 
Jul 21  
Market Cap: 
$1.65B
Trade MDXG now with 

© 2017  
Description of Business
MiMedx® Group, Inc. is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFixTM, and our tissue technologies, AmnioFix® and EpiFix®. For financial information concerning our operating performance, please refer to Management's Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of this report and our Consolidated Financial Statements in Part II, Item 8 of this report.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02. Departure of Directors or Certain ...
      Item 5.07. Submission of Matters to a Vote of Security ...
    SIGNATURES